Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Qiagen N.V. (NY: QGEN ) 45.24 +0.22 (+0.49%) Official Closing Price Updated: 7:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Qiagen N.V. < Previous 1 2 3 4 5 6 Next > QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results March 13, 2023 From QIAGEN N.V. Via Business Wire QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug March 09, 2023 From QIAGEN N.V. Via Business Wire QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing March 01, 2023 From QIAGEN N.V. Via Business Wire QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework February 14, 2023 From QIAGEN N.V. Via Business Wire Will Investors Notice Exciting Sign On Qiagen's Chart? December 20, 2022 Via Benzinga QIAGEN Launches Syndromic Test For QIAstat-Dx For Six Pathogens Similar To Monkeypox August 16, 2022 Via Benzinga QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups February 07, 2023 From QIAGEN N.V. Via Business Wire Genetic Technologies Shares Jump After Strategic Alliance With Qiagen February 01, 2023 Genetic Technologies Limited (NASDAQ: GENE) agreed to form a strategic alliance with Qiagen NV (NYSE: QGEN) to establish and develop a 'Centre of Excellence facility in Australia. Via Benzinga QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs January 17, 2023 From QIAGEN N.V. Via Business Wire QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast January 17, 2023 From QIAGEN N.V. Via Business Wire Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories January 09, 2023 Bloomberg Via Benzinga QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics January 09, 2023 Via Benzinga QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies January 09, 2023 From QIAGEN Via Business Wire QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases January 05, 2023 From QIAGEN N.V. Via Business Wire QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer December 13, 2022 From QIAGEN N.V. Via Business Wire QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance November 21, 2022 From QIAGEN N.V. Via Business Wire QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook November 07, 2022 From QIAGEN N.V. Via Business Wire A Preview Of Qiagen's Earnings November 04, 2022 Qiagen (NYSE:QGEN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Qiagen will report an... Via Benzinga Earnings Scheduled For November 7, 2022 November 07, 2022 Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. Via Benzinga QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast October 21, 2022 From QIAGEN N.V. Via Business Wire Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely October 11, 2022 One analyst doubts any deal could come to fruition. If it did, it would make sense. Via Investor's Business Daily Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11 October 11, 2022 Reuters US-China Chip War: KLA Relaxes Chip Supply To China Via Benzinga Bio-Rad Laboratories, Qiagen Mull Merger Of Equals October 11, 2022 Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all. Via Benzinga FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests September 27, 2022 Via Benzinga COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns September 23, 2022 The World Health Organization (WHO) warned that it struggles to identify and Via Benzinga IGI Inex Holding (UK) Becomes Strategic Investor in Quantumrock, Cementing Partnership Between Leading Global Investment Group and AI Asset Tech Frontrunners September 16, 2022 Via ACCESSWIRE QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System September 15, 2022 From QIAGEN N.V. Via Business Wire QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug September 14, 2022 From QIAGEN N.V. Via Business Wire No More Free COVID-19 At-Home Tests, Federal Government Says August 29, 2022 CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au Via Benzinga QIAGEN Issues 2021 Sustainability Report August 18, 2022 From QIAGEN N.V. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.